The Central Role of the Rheumatologist in the Management of SARD-ILD: Current Guidance for Screening, Monitoring, and Treatment
Released On
May 31, 2025
Expires On
May 30, 2026
Media Type
Internet
Completion Time
60 minutes
Specialty
Rheumatology
Topic(s)
Interstitial Lung Disease (ILD), Systemic Rheumatic Autoimmune Diseases (SARD)
Providers/Grant Support
This activity is supported by an independent medical educational grant from Boehringer Ingelheim Pharmaceuticals, Inc..
Credit Available
- Physicians — maximum of 1.0 AMA PRA Category 1 Credit™
- Nurses — 1.0 Nursing Contact Hour
- PAs — maximum of 1.0 AAPA Category 1 CME credit
All other health care professionals completing this course will be issued a statement of participation.
Target Audience
This educational activity is intended for rheumatologists and other members of the health care team who care for patients with SARD-ILD.
Program Overview
Explore the latest in SARD-ILD care and learn to identify and manage interstitial lung disease earlier and more effectively. This initiative, designed for rheumatologists, will equip learners with up-to-date knowledge on screening, diagnosis, and treatment of ILD in systemic rheumatic diseases. Stay current with evolving guidelines, cutting-edge research, and emerging therapies while enhancing clinical decision-making through real-world case discussions.
Learning Objectives
Upon completion of this activity, participants should be better able to:
- Describe the prevalence, morbidity and mortality, and burden of disease of interstitial lung disease (ILD) across various systemic rheumatic autoimmune diseases (SARDs)
- Assess best practices for the screening and monitoring of ILD in patients with SARD, in accordance with current guidelines
- Summarize the latest developments in the clinical management of SARD-ILD, including new treatment guidelines, clinical research, and emerging therapies
Faculty
Flavia Castelino, MD
Associate Professor of Medicine, Harvard Medical School
Director, Scleroderma Program
Director, Research Training
Massachusetts General Hospital
Boston, MA
Bryant England, MD, PhD
Associate Professor, Division of Rheumatology
University of Nebraska Medical Center
Omaha, NE
Accreditation Statement
In support of improving patient care, The France Foundation is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the health care team.
Credit Designation
Physician Credit Designation
The France Foundation designates this enduring activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nurses
The France Foundation designates this activity for 1.0 contact hour.
Physician Associates
The France Foundation has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.0 AAPA Category 1 CME credit. Approval is valid until 5/29/26. PAs should only claim credit commensurate with the extent of their participation.
All other health care professionals completing this course will be issued a statement of participation.
Disclosures of Conflicts of Interest
Flavia Castelino, MD
- Non-CE Consulting: Boehringer Ingelheim, Mediar Therapeutics, Takeda
- Contract Research: Prometheus, Genentech, Horizon, Boehringer Ingelheim
Bryant England, MD, PhD
- Non-CE Consulting: Boehringer Ingelheim
- Contract Research: Boehringer Ingelheim
Mechanisms implemented to resolve conflicts of interest:
All final planning decisions concerning content, learning objectives, and evaluation questions were made by a non-conflicted planning committee member.
Content was reviewed by a non-conflicted member of the planning committee to ensure that it is not commercially biased, is fair-balanced, and is based on scientific evidence and/or clinical reasoning.
Instructions for Participation and Credit
There are no fees for participating and receiving CME credit for this enduring activity. To receive CME credit, participants must:
- Read the CME/CE information and faculty disclosures.
- Participate in the online activity.
- Submit the evaluation form.
Certificates will be available for immediate download to the participant.
Course Viewing Requirements
Supported Browsers:
Internet Explorer 8.0+ for Windows 2003, Vista, XP, Windows 7, Windows 8.1 and above
Google Chrome 28.0+ for Windows, Mac OS, or Linux
Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux
Safari 6.0+ for Mac OSX 10.7 and above
Supported Phones & Tablets
Android 4.0.3 and above
iPhone/iPad with iOS 6.1 or above
Disclosure of Unlabeled Use
The France Foundation (TFF) requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.
Disclaimer
This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.
Contact Information
For CME questions, please contact [email protected]